North John F
North John F's purchase track record
North John F has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/8/2024 | XPEL | $97K | -1.7% | +29.3% | +14.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
XPEL Meets Growth-at-Reasonable-Price Criteria. ChartMill reported that XPEL Inc. satisfies its growth-at-a-reasonable-price criteria. The assessment highlights the company's ability to combine earnings growth with a valuation that is not excessive. The stock is currently near a long‑term support level, matching the technical snapshot.
Transaction History
| GRND | ▼ Sell | Tax Withholding | 36,888 | $523K | 10/1/2026 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 441 | — | 9/10/2026 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 532 | — | 6/16/2026 | View on chart |
| GRND | ▼ Sell | Tax Withholding | 4,385 | $53K | 4/6/2026 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 532 | — | 3/16/2026 | View on chart |
| GRND | ▲ Buy | Grant | 18,003 | $0 | 3/12/2026 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 532 | — | 12/16/2025 | View on chart |
| GRND | ▲ Buy | Grant | 730,000 | $0 | 10/1/2025 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 532 | — | 9/16/2025 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 530 | — | 6/14/2025 | View on chart |
| XPEL | ▲ Buy | Grant | 616 | $18K | 4/1/2025 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 530 | — | 3/14/2025 | View on chart |
| XPEL | ▲ Buy | Grant | 453 | $18K | 1/1/2025 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 530 | — | 12/14/2024 | View on chart |
| XPEL | ▲ Buy | Grant | 417 | $18K | 10/1/2024 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 530 | — | 9/14/2024 | View on chart |
| XPEL | ▲ Buy | Grant | 509 | $18K | 7/1/2024 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 233 | — | 5/24/2024 | View on chart |
| XPEL | ▲ Buy | Open Market | 3,000 | $97K | 5/8/2024 | View on chart |
| XPEL | ▲ Buy | Grant | 335 | $18K | 4/1/2024 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 232 | — | 2/24/2024 | View on chart |
| XPEL | ▲ Buy | Option Exercise | 232 | — | 11/24/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Grindr Expands HIV Prevention with New Deal and Acquisition
Grindr announced a new partnership with Freddie to support HIV prevention services. The company also bought PurposeMed for $250 million, adding telehealth for PrEP. These moves broaden Grindr’s role in HIV care and could increase its user base. The deal signals a shift toward health services beyond dating.
Grindr Expands HIV Prevention with New Deal and Acquisition. Grindr announced a new partnership with Freddie to support HIV prevention services. The company also bought PurposeMed for $250 million, adding telehealth for PrEP. These moves broaden Grindr’s role in HIV care and could increase its user base. The deal signals a shift toward health services beyond dating.